Get your Pfizer COVID-19 vaccine. Walk-ins welcome! Monday through Thursday: 8 a.m. - 5 p.m. and Friday: 8 a.m. - noon. >

Xuping Li

Xuping Li, MD, PhD

Assistant Research Professor of Neuroscience in Oncology, Academic Institute
Assistant Research Member, Research Institute
Houston Methodist
Weill Cornell Medical College


XLI2@HoustonMethodist.org
Areas Of Expertise

Drug repositioning Neurodegenerative disease
Publications

The Progress of Label-Free Optical Imaging in Alzheimer’s Disease Screening and Diagnosis
Liu, K, Li, J, Raghunathan, R, Zhao, H, Li, X & Wong, STC 2021, , Frontiers in Aging Neuroscience, vol. 13, 699024. https://doi.org/10.3389/fnagi.2021.699024

OCIAD1 contributes to neurodegeneration in Alzheimer’s disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages
Li, X, Wang, L, Cykowski, MD, He, T, Liu, T, Chakranarayan, J, Rivera, A, Zhao, H, Powell, SZ-E, Xia, W & Wong, ST 2020, , EBioMedicine, vol. 51, 102569. https://doi.org/10.1016/j.ebiom.2019.11.030

E-BOOK: LINKING NEUROINFLAMMATION AND GLIAL PHENOTYPIC CHANGES IN NEUROLOGICAL DISEASES
Tang, Y, Li, X & Mao, X 2020, . in YU TANG, X Li & XIAOBO MAO (eds), LINKING NEUROINFLAMMATION AND GLIAL PHENOTYPIC CHANGES IN NEUROLOGICAL DISEASES . Frontiers Journals Series, Frontiers Media S. A. Lausanne.

Editorial: Linking Neuroinflammation and Glial Phenotypic Changes in Neurological Diseases
Tang, Y, Li, X & Mao, X 2019, , Frontiers in Cellular Neuroscience, vol. 13.

Integration of multiscale dendritic spine structure and function data into systems biology models
Mancuso, JJ, Cheng, J, Yin, Z, Gilliam, JC, Xia, X, Li, X & Wong, STC 2014, , Frontiers in Neuroanatomy, vol. 8, no. November, 130. https://doi.org/10.3389/fnana.2014.00130

Transcriptional signaling pathways inversely regulated in Alzheimer's disease and glioblastoma multiform
Liu, T, Ren, D, Zhu, X, Yin, Z, Jin, G, Zhao, Z, Robinson, D, Li, X, Wong, K, Cui, K, Zhao, H & Wong, STC 2013, , Scientific Reports, vol. 3, 3467. https://doi.org/10.1038/srep03467

Vasodilation by in vivo activation of astrocyte endfeet via two-photon calcium uncaging as a strategy to prevent brain ischemia
Chen, Y, Mancuso, J, Zhao, Z, Li, X, Cheng, J, Roman, G & Wong, STC 2013, , Journal of Biomedical Optics, vol. 18, no. 12, 126012. https://doi.org/10.1117/1.JBO.18.12.126012

Methods of dendritic spine detection: From Golgi to high-resolution optical imaging
Mancuso, JJ, Chen, Y, Li, X, Xue, Z & Wong, STC 2013, , Neuroscience, vol. 251, pp. 129-140. https://doi.org/10.1016/j.neuroscience.2012.04.010

In vivo optical activation of astrocytes as a potential therapeutic strategy for neurodegenerative diseases
Chen, Y, Mancuso, J, Zhao, Z, Li, X, Xue, Z & Wong, ST 2013, . in Photonic Therapeutics and Diagnostics IX. vol. 8565, 85655K, Photonic Therapeutics and Diagnostics IX, San Francisco, CA, United States, 2/2/13. https://doi.org/10.1117/12.2004712

Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimers treatment
Mancuso, J, Chen, Y, Zhao, Z, Li, X, Xue, Z & Wong, ST 2013, . in Photonic Therapeutics and Diagnostics IX. vol. 8565, 85655M, Photonic Therapeutics and Diagnostics IX, San Francisco, CA, United States, 2/2/13. https://doi.org/10.1117/12.2004379

A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration
Li, X, Xie, WJ, Zhang, Z, Kansara, S, Jankovic, J & Le, W 2012, , NeuroSignals, vol. 20, no. 4, pp. 223-236. https://doi.org/10.1159/000332954

Anti-Parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease
Zhang, Z, Li, X, Xie, WJ, Tuo, H, Hintermann, S, Jankovic, J & Le, W 2012, , CNS and Neurological Disorders - Drug Targets, vol. 11, no. 6, pp. 768-773. https://doi.org/10.2174/187152712803581155

Nurr1 regulates Top IIß and functions in axon genesis of mesencephalic dopaminergic neurons
Heng, X, Jin, G, Zhang, X, Yang, D, Zhu, M, Fu, S, Li, X & Le, W 2012, , Molecular Neurodegeneration, vol. 7, no. 1, 4. https://doi.org/10.1186/1750-1326-7-4

Iron chelation and neuroprotection in neurodegenerative diseases.
Li, X, Jankovic, J & Le, W 2011, , Journal of neural transmission (Vienna, Austria : 1996), vol. 118, no. 3, pp. 473-477. https://doi.org/10.1007/s00702-010-0518-0

Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease
Xie, W, Li, X, Li, C, Zhu, W, Jankovic, J & Le, W 2010, , Journal of Neurochemistry, vol. 115, no. 1, pp. 188-199. https://doi.org/10.1111/j.1471-4159.2010.06914.x

Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration
Zhu, W, Li, X, Xie, W, Luo, F, Kaur, D, Andersen, JK, Jankovic, J & Le, W 2010, , Neurobiology of Disease, vol. 37, no. 2, pp. 307-313. https://doi.org/10.1016/j.nbd.2009.09.024

Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: Possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease
Ming, M, Li, X, Fan, X, Yang, D, Li, L, Chen, S, Gu, Q & Le, W 2009, , Journal of Translational Medicine, vol. 7, 53. https://doi.org/10.1186/1479-5876-7-53

C-Jun N-Terminal kinase mediates lactacystin-induced dopamine neuron degeneration
Li, X, Du, Y, Fan, X, Yang, D, Luo, G & Le, W 2008, , Journal of Neuropathology and Experimental Neurology, vol. 67, no. 10, pp. 933-944. https://doi.org/10.1097/NEN.0b013e318186de64

Nr4a2 is essential for the differentiation of dopaminergic neurons during zebrafish embryogenesis
Luo, GR, Chen, Y, Li, XP, Liu, TX & Le, WD 2008, , Molecular and Cellular Neuroscience, vol. 39, no. 2, pp. 202-210. https://doi.org/10.1016/j.mcn.2008.06.010

Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo
Yunlan, DU, Xuping, LI, Yang, D, Zhang, X, Chen, S, Huang, K & Le, W 2008, , Experimental Biology and Medicine, vol. 233, no. 7, pp. 881-890. https://doi.org/10.3181/0712-RM-329

VIEW FULL PUBLICATIONS